Jonathan Himmelfarb, MD attended the George Washington University School of Medicine. Following internship and residency in Internal Medicine at Maine Medical Center, he pursued research training in nephrology at the Brigham and Women’s Hospital at Harvard, and further clinical training at Maine Medical Center in Portland. Since then, while establishing a research career of international stature, he has served as Director of the Maine Medical Center transplant program and as its interim Chief of Medicine and Associate Chair for Research.
Recognized nationally and internationally for his expertise in the area of dialysis, Dr. Himmelfarb has made significant contributions to leading renal societies and foundations, served as chair of the American Society of Nephrology Dialysis Advisory Group and served on the board of advisors to the American Society of Nephrology. He has served on numerous editorial boards, including Kidney International and the Journal of the American Society of Nephrology, and is currently chair of the Public Policy Board for the American Society of Nephrology.
“It is time to aggressively seek new approaches to identifying kidney disease early and preventing its progression; discover better predictors of kidney-disease associated risk; find new, effective treatments for advanced kidney disease through relevant research; and then translate these discoveries back into direct and improved care for the patient,” said Dr. Himmelfarb.
